(Reuters) – The European Union’s drug regulator said on Monday it was evaluating data on booster doses of the COVID-19 vaccine by Johnson & Johnson and a decision could come “within weeks” under a speedy review.
The application is for use of a booster dose of the vaccine, COVID-19 Vaccine Janssen, to be given at least two months after the first dose to people aged 18 years and older, the European Medicines Agency (EMA) said https://www.ema.europa.eu/en/news/ema-evaluating-data-booster-dose-covid-19-vaccine-janssen.
(Reporting by Pushkala Aripaka in Bengaluru; Editing by Shinjini Ganguli)
